The FDA is advising U.S. healthcare providers and patients to stop using any plastic syringes in their inventories that were made in China, if possible, as it looks into a spate of quality complaints.

The FDA's Center for Devices and Radiological Health published a statement Tuesday that said issues regarding Chinese-made plastic syringes distributed in the U.S. are "more widespread" than ...

Signed PO secures first 12 months of syringe product orders against Sharps and Nephron’s five-year, $200 million Syringe Sales Agreement. Current Asset Purchase Agreement closing timeline is on track ...

The U.S. Food and Drug Administration's Center for Devices and Radiological Health has warned that Chinese-made plastic syringes that are distributed in the U.S. have "more widespread" quality control ...